calcium folinate

The drug is used to reduce toxicity and neutralize the effects of antineoplastic drugs (including methotrexate), as well as as part of combination therapy with 5-fluorouracil. It is also used for the prevention and treatment of folate deficiency and megaloblastic anemia if oral administration is not possible.

Form: solution for injection or infusion

ATC: V03AF03

Manufacturer: JSC "Gryndeks" (manufacturer responsible for batch control/testing)

The drug is used to reduce toxicity and neutralize the effects of folic acid antagonists (e.g., methotrexate) during chemotherapy. It is also used as part of combination therapy with 5-fluorouracil and for the treatment of megaloblastic anemia if oral folic acid administration is not possible.

Form: solution for injection

ATC: V03AF03

Manufacturer: Haupt Pharma Wolfratshausen GmbH

The drug is used to reduce toxicity and counteract the effects of folic acid antagonists (e.g., methotrexate) during chemotherapy or in cases of overdose. It is also used as part of combination therapy with 5-fluorouracil.

Form: solution for injection

ATC: V03AF03

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (release for batch release)

The drug is used to protect the body from the toxic effects of methotrexate (specifically in osteosarcoma), to reduce intoxication in cases of overdose with methotrexate or other similar agents, and to treat megaloblastic anemia caused by folic acid deficiency. It is also used in combination with 5-fluorouracil for the treatment of colorectal cancer.

Form: solution for injection

ATC: V03AF03

Manufacturer: Venus Remedies Limited